Nanoparticles carrying fingolimod and methotrexate enables targeted induction of apoptosis and immobilization of invasive thyroid cancer
Authors: E. Niemelä, D. Desai, R. Niemi, M. Doroszko, E. Özliseli, K. Kemppainen, N.A. Rahman, C. Sahlgren, K. Törnquist, J.E. Eriksson, J.M. Rosenholm
Journal:European Journal of Pharmaceutics and Biopharmaceutics
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
